» Articles » PMID: 1346670

Breast Cancer Treatment and Natural History: New Insights from Results of Screening

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 1992 Feb 15
PMID 1346670
Citations 23
Authors
Affiliations
Soon will be listed here.
Citing Articles

Evaluating Treatment Outcomes in Women with Node-Negative T1 Breast Cancers.

Chan P, Ong K, Kuah S, Sim E, Chen J, Goh M Cancers (Basel). 2025; 16(24.

PMID: 39766127 PMC: 11727167. DOI: 10.3390/cancers16244228.


Molecular Subtype May Be More Associated With Prognosis and Chemotherapy Benefit Than Tumor Size in T1N0 Breast Cancer Patients: An Analysis of 2,168 Patients for Possible De-Escalation Treatment.

Zhu S, Li Y, Chen W, Fei X, Shen K, Chen X Front Oncol. 2021; 11:636266.

PMID: 33680973 PMC: 7933524. DOI: 10.3389/fonc.2021.636266.


 .

Jaraj D, Hoijer J, Widman L, Ahlgren J, Arnesson L, Einbeigi Z JNCI Cancer Spectr. 2021; 5(1).

PMID: 33442658 PMC: 7791632. DOI: 10.1093/jncics/pkaa084.


Early stage triple negative breast cancer: Management and future directions.

Chaudhary L Semin Oncol. 2020; 47(4):201-208.

PMID: 32507668 PMC: 7446736. DOI: 10.1053/j.seminoncol.2020.05.006.


Observed and Predicted Risk of Breast Cancer Death in Randomized Trials on Breast Cancer Screening.

Autier P, Boniol M, Smans M, Sullivan R, Boyle P PLoS One. 2016; 11(4):e0154113.

PMID: 27100174 PMC: 4839680. DOI: 10.1371/journal.pone.0154113.